FC SmithRx Series C, LP — Form D
FC SmithRx Series C, LP of NEWTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-11-16. $1.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-11-16
- Form: D
- Accession: 0001996800-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $1.6M
- Investors: 16
- Date of first sale: 2023-11-16
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-497434
Issuer
- Name: FC SmithRx Series C, LP
- CIK: 0001996800
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 139 GIBBS STREET, NEWTON, MA, 02459
- Phone: 978-273-7692
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Louis Beryl | Executive Officer | SALT LAKE CITY, UT |
| N/A FOUR CITIES FUND V GP, LLC | Executive Officer | NEWTON, MA |
| Matthew McKnight | Executive Officer | NEWTON, MA |
More